作者: Steven K. Takemoto , Wolfgang Arns , Suphamai Bunnapradist , Louis P. Garrison , Lluis Guirado
DOI: 10.1097/TP.0B013E31817D4DF5
关键词:
摘要: Transplantation offers a unique opportunity to demonstrate the complementary roles of randomized controlled trials and outcome research. The surgery collaboration necessary for transplant procedure makes randomization blinding difficult. Because essentially every recipient is included in registry, sampling bias minimized. Regulatory agencies generally do not consider outcomes research when assessing efficacy new drugs or medical interventions. This workgroup summary examines suitability complement results related issues: versus effectiveness, internal external validity, data types, limitations, analysis methodologies. Many advances have been pioneered transplantation. A case made regulatory reimbursement authorities use making efficacy, coverage decisions